Sharobel Kit
Product Images NDC 16714-441

4 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sharobel (NDC 16714-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Norethindrone Structure (Norethindrone)

Norethindrone Structure (Norethindrone)
Chemical structure of norethindrone, showing its steroidal backbone with specific functional groups including a ketone and hydroxyl group, labeled with the generic name below the diagram.*
FDA Label Image

Carton (Sharobel 6cycle)

Carton (Sharobel 6cycle)
SHAROBEL Norethindrone Tablets, USP 0.35 mg kit packaging label from Northstar Rx LLC. The label shows it contains 6 blister cards, each with 28 tablets. The label includes usage warnings, storage instructions, and a barcode, featuring purple and blue floral graphics on a white background.*
FDA Label Image

Table I (Table 1 2)

Table I (Table 1 2)
A table presenting the percentage of women experiencing unintended pregnancy during the first year of use and first-year perfect use of various contraception methods, alongside the percentage of women continuing use at one year in the United States. Methods listed include chance, spermicides, periodic abstinence methods, Cap, sponge, diaphragm, withdrawal, condom, pill, IUD, Depo-Provera, female sterilization, and male sterilization, with detailed data for typical and perfect use and continuation rates.*
FDA Label Image

Table Ii (Table 2 6)

Table Ii (Table 2 6)
This table presents the percentage of women experiencing unintended pregnancy within the first year of typical and perfect use of various contraception methods, along with the percentage continuing use at one year in the United States. Methods include chance, spermicides, periodic abstinence, cap, sponge, diaphragm, withdrawal, condom, pill, IUD, Depo-Provera, sterilization, and others, differentiated by use type and user demographics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.